Action Changement Date
Amgen USD 6.39B 169M 2026-09
Anika Therapeutics USD 28.56M 5.73M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.93B 362M 2026-06
BioMarin Pharmaceutical USD 1.8B 13.54M 2026-09
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Daiichi Sankyo JPY 733.05B 40.68B 2026-06
Eli Lilly USD 18.19B 1.4B 2026-09
Halozyme Therapeutics USD 132.61M 4.52M 2026-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Intrexon USD 287K 68K 2022-12
Ionis Pharmaceuticals USD 28.58M 22.26M 2026-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Ligand Pharmaceuticals USD 14.51M 4.24M 2026-09
MacroGenics USD 9.5M 1.59M 2026-03
Neurocrine Biosciences USD 66.1M 38.1M 2026-09
Pfizer USD 10.02B 77M 2026-09
Regeneron Pharmaceuticals USD 2.89B 189.7M 2026-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Ultragenyx Pharmaceutical USD 59M 0 2026-09
Veracyte USD 25.82M 3.16M 2026-09